European Nuclear Medicine Guide

7. Neuroendocrine Tumors

• 7.1.

  Indication: Neuroendocrine Tumours
• 7.2.

  [¹⁷⁷Lu]Lutetium ([¹⁷⁷Lu]Lu-DOTA0, Tyr3) oxodotreotide
• 7.3.

  [⁹⁰Y]Yttrium ([⁹⁰Y]Y-DOTA0, Tyr3) octreotide or [⁹⁰Y]Y-DOTA-TOC
• 7.4.

  Alpha-Emitters in Neuroendocrine Tumours
• 7.5.

  References